We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Hemoglobin Levels Measured with AI Microscope, Microfluidic Chips

By LabMedica International staff writers
Posted on 10 Mar 2021
A complete blood count can help ascertain the health of a patient and typically includes an estimate of the hemoglobin concentration, which can indicate several conditions, including anemia, polycythemia, and pulmonary fibrosis.

All techniques used in the estimation of hemoglobin in the blood can be classified into invasive and non-invasive. More...
Non-invasive techniques, though very convenient because of the absence of needle prick, suffer from inferior performance; therefore, these techniques are almost always used as screening tools.

Bioengineers at Sigtuple Technologies (Bengaluru, India) and the Indian Institute of Science (Bengaluru, India) have developed a new AI-powered imaging-based tool to estimate hemoglobin levels. The setup was developed in conjunction with a microfluidic chip and an AI-powered automated microscope that was designed for deriving the total as well as differential counts of blood cells. The assay parameters, including SLS reagent-to-blood volume ratio, total reaction volume, the concentration of sodium dodecyl sulfate, and microfluidic chamber design, were optimized in order to achieve quantitation capability across a clinical range of hemoglobin using a path length suitable for the microfluidic platform.

Besides quantitative correlation with a clinically accepted-validated standard method, the spectral absorption characteristics of the hemoglobin–SLS reagent mixture in the newly developed assay were compared with those of conventional SLS assays. The SLS–blood/Hb standard solutions were analyzed using Erba Chem 5× clinical chemical analyzer (ERBA Diagnostics GmbH, Mannheim, Germany), and for hemoglobin estimation, the recommended settings with absorbance measurement at 546 nm were used. All UV–vis absorption measurements were performed using the NanoPhotometer NP 80, IMPLEN, Munich, Germany). The hemoglobin concentrations of both blood samples and in-house prepared hemoglobin standard solutions were measured using a commercial XP-100 hematology analyzer (Sysmex, Kobe, Japan).

The scientists reported that the microfluidic chip in combination with an automated microscope was able to achieve a Pearson correlation of 0.99 in a validation study comparing the newly developed method and a commercially available hematology analyzer, with a turnaround time of 10 minutes, including incubation time. The clinical performance was ascertained, and the method achieved a sensitivity of 92.3% and a specificity of 53.8%.

The automated microscope, which normally uses a combination of the red, green, and blue LED, used just the green LED during the hemoglobin estimation mode, and additionally, the grayscale values from the green channel of the image generated by an e-con camera. These optimized parameters, including exposure time, gain, white balance, and local tone mapping, were found to result in a setup capable of measuring hemoglobin in the blood, which was demonstrated through a clinical verification with 27 blood samples. Besides measuring hemoglobin in the blood, a similar setup with minor modifications could be used to measure protein content, cholesterol, and glycated hemoglobin. The study was published on February 23, 2021 in the journal AIP Advances.

Related Links:
Sigtuple Technologies
Indian Institute of Science
ERBA Diagnostics
IMPLEN
Sysmex



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.